Archangel — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Mesosilmesosil.comJul 2021
Mesosil develops nanomaterial platform technology for dental materials and other applications, focusing on host-biomaterial interactions and infection prevention.
BiotechDeep TechMedical DevicesNew MaterialsToronto, CA
Cameron Stewart(Founder & CEO)inSepehr Tehrani(Director of Operations)inNeda Aslankoohhi(Director of Research)
Co-investorsGreenSky VenturesArchangel Network of Funds
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.